BRCA1/2 can also serve as biomarkers since reduced expression of BRCA1/2, due to mutations or epigenetic inactivation, leads to impaired mammary gland differentiation and increased risk of breast cancer development [31]. Here, BRCA1 is linked to breast cancer.